1-(2,3-Dibenzimidazol-2-ylpropyl)-2-methoxybenzene Is a Syk Inhibitor with Anti-Inflammatory Properties

Molecules

Volumn 21, Issue 4, 2016, Pages

  Kim, Eunji ^a   Son, Young Jin ^b   Yang, Yanyan ^a,c   Shen, Ting ^d   Kim, Ikyon ^e   Aravinthan, Adithan ^f   Kim, Jong Hoon ^f   Cho, Jae Youl ^a  

^a Sungkyunkwan University   (South Korea)

^b Sunchon National University   (South Korea)

^c QINGDAO UNIVERSITY   (China)

^d HUAIYIN NORMAL UNIVERSITY   (China)

^e Yonsei University   (South Korea)

^f Chonbuk National University   (South Korea)

Author keywords

1 (2; 3 dibenzimidazol 2 ylpropyl) 2 methoxybenzene; Inflammatory responses; Nf b; Syk

Indexed keywords

1-(2,3-DIBENZIMIDAZOL-2-YLPROPYL)-2-METHOXYBENZENE; ANISOLE DERIVATIVE; ANTIINFLAMMATORY AGENT; BENZIMIDAZOLE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEIN KINASE SYK;

ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HUMAN; MACROPHAGE; METABOLISM; MOUSE; RAW 264.7 CELL LINE; SIGNAL TRANSDUCTION;

ANIMALS; ANISOLES; ANTI-INFLAMMATORY AGENTS; BENZIMIDAZOLES; DINOPROSTONE; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; RAW 264.7 CELLS; SIGNAL TRANSDUCTION; SYK KINASE;

EID: 84968654882     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21040508     Document Type: Article

References (58)

1. Kim, E.; Yang, W.S.; Kim, J.H.; Park, J.G.; Kim, H.G.; Ko, J.; Hong, Y.D.; Rho, H.S.; Shin, S.S.; Sung, G.-H. Lancemaside A from Codonopsis lanceolata modulates the inflammatory responses mediated by monocytes and macrophages. Mediat. Inflamm. 2014, 2014, 405158.
2. Takeuchi, O.; Akira, S. Pattern recognition receptors and inflammation. Cell 2010, 140, 805-820.
3. Sabroe, I.; Parker, L.; Dower, S.; Whyte, M. The role of TLR activation in inflammation. J. Pathol. 2008, 214, 126-135.
4. De Nardo, D. Toll-like receptors: Activation, signalling and transcriptional modulation. Cytokine 2015, 74, 181-189.
5. Newton, K.; Dixit, V.M. Signaling in innate immunity and inflammation. Cold Spring Harbor Perspect. Biol. 2012, 4, a006049.
6. Jin, J.; Xiao, Y.; Hu, H.; Zou, Q.; Li, Y.; Gao, Y.; Ge, W.; Cheng, X.; Sun, S.-C. Proinflammatory TLR signalling is regulated by a TRAF2-dependent proteolysis mechanism in macrophages. Nat. Commun. 2015, 6, 5930.
7. Kim, C.H.; Park, J.; Kim, M. Gut microbiota-derived short-chain fatty acids, T cells, and inflammation. Immune Netw. 2014, 14, 277-288.
8. Schmitz, F.; Mages, J.; Heit, A.; Lang, R.; Wagner, H. Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: From expression profiling to a model of TLR signaling. Eur. J. Immunol. 2004, 34, 2863-2873.
9. Yi, Y.S.; Son, Y.J.; Ryou, C.; Sung, G.H.; Kim, J.H.; Cho, J.Y. Functional roles of Syk in macrophage-mediated inflammatory responses. Mediat. Inflamm. 2014, 2014, 270302.
10. Kim, M.Y.; Kim, J.H.; Cho, J.Y. Cytochalasin B modulates macrophage-mediated inflammatory responses. Biomol. Ther. 2014, 22, 295-300.
11. Yang, W.S.; Lee, J.; Kim, T.W.; Kim, J.H.; Lee, S.; Rhee, M.H.; Hong, S.; Cho, J.Y. Src/NF-κB-targeted inhibition of LPS-induced macrophage activation and dextran sodium sulphate-induced colitis by Archidendron clypearia methanol extract. J. Ethnopharmacol. 2012, 142, 287-293.
12. Takada, Y.; Mukhopadhyay, A.; Kundu, G.C.; Mahabeleshwar, G.H.; Singh, S.; Aggarwal, B.B. Hydrogen peroxide activates NF-κB through tyrosine phosphorylation of IκBα and serine phosphorylation of p65 evidence for the involvement of IκBα kinase and Syk protein-tyrosine kinase. J. Biol. Chem. 2003, 278, 24233-24241.
13. Hoesel, B.; Schmid, J.A. The complexity of NF-κB signaling in inflammation and cancer. Mol. Cancer 2013, 12, 86.
14. Chang, J.; Kim, B.M.; Chang, C.H. Co-stimulation of TLR4 and Dectin-1 induces the production of inflammatory cytokines but not TGF-β for Th17 cell differentiation. Immune Netw. 2014, 14, 30-37.
15. Kim, J.-B.; Han, A.-R.; Park, E.-Y.; Kim, J.-Y.; Cho, W.; Lee, J.; Seo, E.-K.; Lee, K.-T. Inhibition of LPS-induced iNOS, COX-2 and cytokines expression by poncirin through the NF-κB inactivation in RAW 264.7 macrophage cells. Biol. Pharm. Bull. 2007, 30, 2345-2351.
16. Byeon, S.E.; Yi, Y.-S.; Oh, J.; Yoo, B.C.; Hong, S.; Cho, J.Y. The role of Src kinase in macrophage-mediated inflammatory responses. Mediat. Inflamm. 2012, 2012, 512926.
17. Yang, Y.; Yu, T.; Lian, Y.J.; Ma, R.; Yang, S.; Cho, J.Y. Nitric oxide synthase inhibitors: A review of patents from 2011 to the present. Expert Opin. Ther. Pat. 2015, 25, 49-68.
18. Zamora, R.; Vodovotz, Y.; Billiar, T.R. Inducible nitric oxide synthase and inflammatory diseases. Mol. Med. 2000, 6, 347-373.
19. Ricciotti, E.; FitzGerald, G.A. Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 986-1000.
20. Siegfried, A.; Berchtold, S.; Manncke, B.; Deuschle, E.; Reber, J.; Ott, T.; Weber, M.; Kalinke, U.; Hofer, M.J.; Hatesuer, B. IFIT2 is an effector protein of type I IFN-mediated amplification of lipopolysaccharide (LPS)-induced TNF-α secretion and LPS-induced endotoxin shock. J. Immunol. 2013, 191, 3913-3921.
21. Kang, C.-D.; Han, C.-S.; Kim, K.-W.; Do, I.-R.; Kim, C.-M.; Kim, S.-H.; Lee, E.-Y.; Chung, B.-S. Activation of NF-κB mediates the PMA-induced differentiation of K562 cells. Cancer Lett. 1998, 132, 99-106.
22. Jones, E.; Adcock, I.M.; Ahmed, B.Y.; Punchard, N.A. Modulation of LPS stimulated NF-κB mediated nitric oxide production by PKCepsilon and JAK2 in RAW macrophages. J. Inflamm. 2007, 4, 23.
23. Viatour, P.; Merville, M.-P.; Bours, V.; Chariot, A. Phosphorylation of NF-κB and IκB proteins: Implications in cancer and inflammation. Trends Biochem. Sci. 2005, 30, 43-52.
24. Tak, P.P.; Firestein, G.S. NF-κB: A key role in inflammatory diseases. J. Clin. Investig. 2001, 107, 7-11.
25. Kim, E.; Yoon, K.D.; Lee, W.-S.; Yang, W.S.; Kim, S.H.; Sung, N.Y.; Baek, K.-S.; Kim, Y.; Htwe, K.M.; Kim, Y.-D. Syk/Src-targeted anti-inflammatory activity of Codariocalyx motorius ethanolic extract. J. Ethnopharmacol. 2014, 155, 185-193.
26. Yoon, J.Y.; Jeong, H.Y.; Kim, S.H.; Kim, H.G.; Nam, G.; Kim, J.P.; Yoon, D.H.; Hwang, H.; Kimc, T.W.; Hong, S. Methanol extract of Evodia lepta displays Syk/Src-targeted anti-inflammatory activity. J. Ethnopharmacol. 2013, 148, 999-1007.
27. Hatton, O.; Lambert, S.L.; Krams, S.M.; Martinez, O.M. Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV) + B cell lymphomas. PLoS ONE 2012, 7, e42610.
28. Beitz, L.O.; Fruman, D.A.; Kurosaki, T.; Cantley, L.C.; Scharenberg, A.M. SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling. J. Biol. Chem. 1999, 274, 32662-32666.
29. Jiang, K.; Zhong, B.; Gilvary, D.L.; Corliss, B.C.; Vivier, E.; Hong-Geller, E.; Wei, S.; Djeu, J.Y. Syk regulation of phosphoinositide 3-kinase-dependent NK cell function. J. Immunol. 2002, 168, 3155-3164.
30. Kim, S.H.; Park, J.G.; Lee, J.; Yang, W.S.; Park, G.W.; Kim, H.G.; Yi, Y.-S.; Baek, K.-S.; Sung, N.Y.; Hossen, M.J. The dietary flavonoid kaempferol mediates anti-inflammatory responses via the Src, Syk, IRAK1, and IRAK4 molecular targets. Mediat. Inflamm. 2015, 2015, 904142.
31. Perkins, N.D. The diverse and complex roles of NF-κB subunits in cancer. Nat. Rev. Cancer 2012, 12, 121-132.
32. Hu, J.; Haseebuddin, M.; Young, M.; Colburn, N.H. Suppression of p65 phosphorylation coincides with inhibition of IκBα polyubiquitination and degradation. Mol. Carcinog. 2005, 44, 274-284.
33. Michael, K. How NF-kB is activated: The role of the IkB kinase (IKK) complex. Oncogene 1999, 18, 6867-6874.
34. Lawrence, T. The nuclear factor NF-κB pathway in inflammation. Cold Spring Harbor Perspect. Biol. 2009, 1, a001651.
35. Kwon, D.J.; Bae, Y.S.; Ju, S.M.; Youn, G.S.; Choi, S.Y.; Park, J. Salicortin suppresses lipopolysaccharide-stimulated inflammatory responses via blockade of NF-κB and JNK activation in RAW 264.7 macrophages. BMB Rep. 2014, 47, 318-323.
36. Caamano, J.; Hunter, C.A. NF-κB family of transcription factors: Central regulators of innate and adaptive immune functions. Clin. Microbiol. Rev. 2002, 15, 414-429.
37. Hwang, Y.J.; Song, J.; Kim, H.R.; Hwang, K.A. Oleanolic acid regulates NF-κB signaling by suppressing MafK expression in RAW 264.7 cells. BMB Rep. 2014, 47, 524-529.
38. Crawford, J.M.; Watanabe, K. Cell adhesion molecules in inflammation and immunity: Relevance to periodontal diseases. Crit. Rev. Oral Biol. Med. 1994, 5, 91-123.
39. Sung, N.Y.; Kim, M.-Y.; Cho, J.Y. Scutellarein reduces inflammatory responses by inhibiting Src kinase activity. Korean J. Physiol. Pharmacol. 2015, 19, 441-449.
40. Wan, D.; Jiao, L.; Yang, H.; Liu, S. Structural characterization and immunological activities of the water-soluble oligosaccharides isolated from the Panax ginseng roots. Planta 2012, 235, 1289-1297.
41. Mócsai, A.; Ruland, J.; Tybulewicz, V.L. The SYK tyrosine kinase: A crucial player in diverse biological functions. Nat. Rev. Immunol. 2010, 10, 387-402.
42. Liao, C.; Hsu, J.; Kim, Y.; Hu, D.-Q.; Xu, D.; Zhang, J.; Pashine, A.; Menke, J.; Whittard, T.; Romero, N. Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: Implications for SYK inhibitors in autoimmune disease therapy. Arthritis Res. Ther. 2013, 15, R146.
43. Yu, T.; Ahn, H.M.; Shen, T.; Yoon, K.; Jang, H.-J.; Lee, Y.J.; Yang, H.M.; Kim, J.H.; Kim, C.; Han, M.H. Anti-inflammatory activity of ethanol extract derived from Phaseolus angularis beans. J. Ethnopharmacol. 2011, 137, 1197-1206.
44. Byeon, S.E.; Yu, T.; Yang, Y.; Lee, Y.G.; Kim, J.H.; Oh, J.; Jeong, H.Y.; Hong, S.; Yoo, B.C.; Cho, W.-J. Hydroquinone regulates hemeoxygenase-1 expression via modulation of Src kinase activity through thiolation of cysteine residues. Free Radic. Biol. Med. 2013, 57, 105-118.
45. Kim, J.H.; Lee, Y.G.; Yoo, S.; Oh, J.; Jeong, D.; Song, W.K.; Yoo, B.C.; Rhee, M.H.; Park, J.; Cha, S.-H. Involvement of Src and the actin cytoskeleton in the antitumorigenic action of adenosine dialdehyde. Biochem. Pharmacol. 2013, 85, 1042-1056.
46. Lee, Y.G.; Chain, B.M.; Cho, J.Y. Distinct role of spleen tyrosine kinase in the early phosphorylation of inhibitor of κBα via activation of the phosphoinositide-3-kinase and Akt pathways. Int. J. Biochem. Cell Biol. 2009, 41, 811-821.
47. Cho, J.Y.; Baik, K.U.; Jung, J.H.; Park, M.H. In vitro anti-inflammatory effects of cynaropicrin, a sesquiterpene lactone, from Saussurea lappa. Eur. J. Pharmacol. 2000, 398, 399-407.
48. Green, L.C.; Wagner, D.A.; Glogowski, J.; Skipper, P.L.; Wishnok, J.S.; Tannenbaum, S.R. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal. Biochem. 1982, 126, 131-138.
49. Gerlier, D.; Thomasset, N. Use of MTT colorimetric assay to measure cell activation. J. Immunol. Methods 1986, 94, 57-63.
50. Baek, K.S.; Hong, Y.D.; Kim, Y.; Sung, N.Y.; Yang, S.; Lee, K.M.; Park, J.Y.; Park, J.S.; Rho, H.S.; Shin, S.S.; et al. Anti-inflammatory activity of AP-SF, a ginsenoside-enriched fraction, from Korean ginseng. J. Ginseng Res. 2015, 39, 155-161.
51. Yang, Y.; Lee, J.; Rhee, M.H.; Yu, T.; Baek, K.S.; Sung, N.Y.; Kim, Y.; Yoon, K.; Kim, J.H.; Kwak, Y.S.; et al. Molecular mechanism of protopanaxadiol saponin fraction-mediated anti-inflammatory actions. J. Ginseng Res. 2015, 39, 61-68.
52. Kim, M.Y.; Yoo, B.C.; Cho, J.Y. Ginsenoside-Rp1-induced apolipoprotein A-1 expression in the LoVo human colon cancer cell line. J. Ginseng Res. 2014, 38, 251-255.
53. Yu, T.; Lee, J.; Lee, Y.G.; Byeon, S.E.; Kim, M.H.; Sohn, E.-H.; Lee, Y.J.; Lee, S.G.; Cho, J.Y. In vitro and in vivo anti-inflammatory effects of ethanol extract from Acer tegmentosum. J. Ethnopharmacol. 2010, 128, 139-147.
54. Seo, H.S.; Sikder, M.A.; Lee, H.J.; Ryu, J.; Lee, C.J. Apigenin inhibits tumor necrosis factor-α-induced production and gene expression of mucin through regulating nuclear factor-κB signaling pathway in airway epithelial cells. Biomol. Ther. 2014, 22, 525-531.
55. Shen, T.; Lee, J.; Park, M.H.; Lee, Y.G.; Rho, H.S.; Kwak, Y.-S.; Rhee, M.H.; Park, Y.C.; Cho, J.Y. Ginsenoside Rp1, a ginsenoside derivative, blocks promoter activation of iNOS and COX-2 genes by suppression of an IKKβ-mediated NF-κB pathway in HEK293 cells. J. Ginseng Res. 2011, 35, 200.
56. Song, S.B.; Tung, N.H.; Quang, T.H.; Ngan, N.T.T.; Kim, K.E.; Kim, Y.H. Inhibition of TNF-α-mediated NF-κB transcriptional activity in HepG2 cells by dammarane-type saponins from Panax ginseng leaves. J. Ginseng Res. 2012, 36, 146.
57. Lee, J.-O.; Jeong, D.; Kim, M.-Y.; Cho, J.Y. ATP-binding pocket-targeted suppression of Src and Syk by luteolin contributes to its anti-inflammatory action. Mediat. Inflamm. 2015, 501, 967053.
58. Jeong, D.; Yi, Y.-S.; Sung, G.-H.; Yang, W.S.; Park, J.G.; Yoon, K.; Yoon, D.H.; Song, C.; Lee, Y.; Rhee, M.H. Anti-inflammatory activities and mechanisms of Artemisia asiatica ethanol extract. J. Ethnopharmacol. 2014, 152, 487-496.